Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Cardlytics

Cardlytics Stock Surges 5% After Hours As Citron Research Spotlights Wells Fargo Partnership

Cardlytics Inc. (NASDAQ: CDLX) saw its stock fall 9.85% during regular trading on Thursday. However, the stock rebounded in after-hours trading, climbing 5.04% to $2.50 following positive remarks from analysts.

Cardlytics Stock Soars After Citron Research Says Shares Could 'Double Or Triple' From Here

Cardlytics Stock Soars After Citron Research Says Shares Could 'Double Or Triple' From Here

Shares of Cardlytics, Inc. (NASDAQ:CDLX) are rising on Wednesday after a research firm published a glowing report on the company, which partners with retail outlets and banks to offer cash-back rewards on card purchases.

Cardlytics (CDLX) Stock Soars Over 50% On AmEx News And Citron Tweet

Cardlytics (CDLX) Stock Soars Over 50% On AmEx News And Citron Tweet

Shares of advertising-platform Cardlytics Inc (NASDAQ:CDLX) are surging Thursday morning. The rally was ignited by a bullish tweet from Citron Research connecting Cardlytics to news of the American Express Co (NYSE:AXP) Platinum card refresh.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Is Cardlytics Stock a Buy After Insider's $13.9M Investment?

Cardlytics shares have been on a wild ride this March. Should investors follow suit with massive insider buying, or steer clear of this highly volatile small-cap stock?

Innovid Names Dani Cushion Chief Marketing Officer

Former Cardlytics CMO joins Innovid to drive the ad platform’s global marketing efforts

Holiday spending surges in 2023 despite cost of living crisis

New data suggests shift towards low-cost options and direct bookings

The Independent UK

Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2022

inkl

Read news from The Economist, FT, and more,
with one subscription

Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2022

Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2022

Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2022

Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2022

Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2022

Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2022

Cardlytics's Return On Capital Employed Insights

Cardlytics's Return On Capital Employed Insights

Pulled from Benzinga Pro data, Cardlytics (NASDAQ:CDLX) posted Q1 earnings of $33.04 million, an increase from Q4 of 379.16%. Sales dropped to $67.93 million, a 24.57% decrease between quarters.

Cardlytics: Q1 Earnings Insights

Cardlytics: Q1 Earnings Insights

Cardlytics (NASDAQ:CDLX) reported its Q1 earnings results on Monday, May 2, 2022 at 05:00 PM. Here's what investors need to know about the announcement. Earnings Cardlytics beat estimated earnings by 30.91%, reporting an EPS of $-0.38 versus an estimate of $-0.55.

Earnings Outlook For Cardlytics

Earnings Outlook For Cardlytics

Cardlytics (NASDAQ:CDLX) is set to give its latest quarterly earnings report on Monday, 2022-05-02. Here's what investors need to know before the announcement. Analysts estimate that Cardlytics will report an earnings per share (EPS) of $-0.55.

Cardlytics's Return On Capital Employed Overview

Cardlytics's Return On Capital Employed Overview

According to Benzinga Pro data, during Q4, Cardlytics (NASDAQ:CDLX) posted sales of $90.05 million. Earnings were up 73.42%, but Cardlytics still reported an overall loss of $11.84 million.

Get all your
news in one place.

100's of premium titles.
One news app.

Analysts Remain Bullish On Cardlytics Post Q4 Results

Analysts reiterated a Buy on Cardlytics Inc (NASDAQ:CDLX) post Q4 results. Craig-Hallum analyst Jason Kreyer lowered the firm's price target on Cardlytics from $100 to $70 (15% upside) and kept a Buy. The analyst notes quarterly results were strong despite lingering concerns over the supply chain, labor shortages, and omicron issues faced in the quarter. …

Recap: Cardlytics Q4 Earnings

Cardlytics (NASDAQ:CDLX) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Cardlytics beat estimated earnings by 64.29%, reporting an EPS of $-0.15 versus an estimate of $-0.42.

1

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

American Express

Southwest Airlines

Advanced Micro Devices

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play